di chen
Dalian Institute of Chemical Physics, Chinese Academy of Sciences (CAS)
Dalian, China
Review Editor
Cancer Molecular Targets and Therapeutics
Dalian Institute of Chemical Physics, Chinese Academy of Sciences (CAS)
Dalian, China
Review Editor
Cancer Molecular Targets and Therapeutics
First Affiliated Hospital, Nanjing Medical University
Nanjing, China
Review Editor
Cancer Molecular Targets and Therapeutics
University of Kentucky
Lexington, United States
Review Editor
Cancer Molecular Targets and Therapeutics
National Health Research Institutes (Taiwan)
Hsinchu, Taiwan
Review Editor
Cancer Molecular Targets and Therapeutics
Sun Yat-sen University Cancer Center (SYSUCC)
Guangzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
Beijing University of Chinese Medicine
Beijing, China
Review Editor
Cancer Molecular Targets and Therapeutics
The University of Iowa
Iowa City, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Nationwide Children's Hospital
Columbus, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Guangzhou University of Chinese Medicine
Guangzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences (CAS)
Kunming, China
Review Editor
Cancer Molecular Targets and Therapeutics
IFOM - The FIRC Institute of Molecular Oncology
Milan, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Heidelberg University Hospital
Heidelberg, Germany
Review Editor
Cancer Molecular Targets and Therapeutics
Houston Methodist Research Institute
Houston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of Padua
Padua, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
University of L'Aquila
L'Aquila, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
University of Cagliari
Cagliari, Italy
Review Editor
Cancer Molecular Targets and Therapeutics